Celldex Therapeutics reported $16.29M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 173.07M 13.35M
Amgen AMGN:US USD 15.69B 1.36B
Aptinyx Inc APTX:US USD 2.69M 2.99M
Biocept BIOC:US USD 7.15M 2.46M
Celldex Therapeutics CLDX:US USD 16.29M 13.66M
Cytrx CYTR:US USD 3.1M 633.56K
Glaxosmithkline GSK:US GBP 22.81B 1.86B
Immunogen IMGN:US USD 103.64M 16.57M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Newlink Genetics NLNK:US USD 5.48M 651K
Northwest Biotherapeutics NWBO:US USD 116.13M 17.97M
Rigel Pharmaceuticals RIGL:US USD 47.26M 7.69M
Roche Holding ROG:VX 27.41B 11.01B
Seattle Genetics SGEN:US USD 726M 117.48M